Jan Kvasnička

Jan Kvasnička

Auto-generated profile, based on publicly available information

Jan Kvasnička

Institute of Medical Biochemistry and Laboratory Diagnostics, the Thrombosis Center, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
INIvan Netuka
Ivan Netuka
TKTomas Kvasnicka
Tomas Kvasnicka
JKJan Kvasnička
Jan Kvasnička
IHIngrid Hrachovinová
Ingrid Hrachovinová
PIPeter Ivák
Peter Ivák
MMMandeep Mehra
Mandeep Mehra

27 April 2012 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
PDF file
JŠJan Škrha
Jan Škrha
MKMarta Kalousova
Marta Kalousova
JŠJ. Švarcová
J. Švarcová
AMA. Muravská
A. Muravská
JKJ. Kvasnička
J. Kvasnička
JŠJan Škrha
Jan Škrha
Receptor for advanced glycation endproducts (RAGE) plays the essential role in the pathogenesis of diabetic vascular complications. The aim of the study was to compare concentration of soluble RAGE and its ligands (EN-RAGE and HMGB1) with different biochemical parameters in Type 1 (T1DM) and Type 2 (T2DM) diabetes mellitus.Total number of 154 persons (45 T1DM, 68 T2DM, 41 controls) was examined and concentrations of sRAGE, EN-RAGE and HMGB1 were measured and compared to diabetes control, albuminuria, cell adhesion molecules and metalloproteinases (MMPs).Mean serum sRAGE concentration was higher in T1DM as compared to controls (1137±532 ng/l vs. 824±309 ng/l, p<0.01). Similarly, EN-RAGE was significantly higher in both diabetic groups (p<0.001) and HMGB1 concentrations were elevated in T2DM patients (p<0.01). Significant relationship was found between MMP9 and HMGB1 and EN-RAGE in diabetic patients. Inverse relationship was observed between MMP2 and MMP9 in both types of diabetic patients (r= − 0.602, p<0.002 and r= − 0.771, p<0.001). Significant positive correlation was found between sRAGE and ICAM-1, VCAM-1 or vWF (p<0.01 to p<0.001).We conclude that serum sRAGE and RAGE ligands concentrations reflect endothelial dysfunction developing in diabetes.

1 August 2002 in Journal of Human Hypertension
Verified
Journal Article
Closed access
ZHZ Hlubocká
Z Hlubocká
VUV Umnerová
V Umnerová
SHS Heller
S Heller
JPJ Peleska
J Peleska
AJA Jindra
A Jindra
MAM Aschermann
M Aschermann

1 April 1999 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
JŠJ. Škrha
J. Škrha
GŠG. Šindelka
G. Šindelka
JKJ. Kvasnička
J. Kvasnička
JHJ. Hilgertová
J. Hilgertová

1 August 2007 in Neuroimmunomodulation
Verified
Journal Article
Closed access
TZTomáš Zelinka
Tomáš Zelinka
OPOndrej Petrak
Ondrej Petrak
BŠBranislav Štrauch
Branislav Štrauch
RHRobert Holaj
Robert Holaj
JKJan Kvasnička
Jan Kvasnička
JWJiri Widimsky
Jiri Widimsky
Objective: To investigate the effect of long-term catecholamine excess in pheochromocytoma on leukocyte and platelet count and on proteins of acute-phase response. Methods: Fifteen subjects with pheochromocytoma, 16 with primary aldosteronism, 18 with essential hypertension and 17 healthy controls were studied. Sixteen subjects with pheochromocytoma were investigated after tumor removal. Leukocyte, neutrophil and platelet count, as well as C-reactive protein were measured in all subjects, while fibrinogen, α1-antitrypsin, α2-macroglobulin, orosomucoid, transferrin and prealbumin were only measured in subjects with pheochromocytoma, primary aldosteronism and essential hypertension. Results: Subjects with pheochromocytoma showed significantly higher leukocyte [7.5 ± 0.9 109/l, p < 0.001 vs. primary aldosteronism (5.4 ± 0.9 109/l) and healthy controls (5 ± 0.9 109/l), p = 0.04 vs. essential hypertension (6.3 ± 1.6 109/l)], neutrophil (p < 0.001 vs. primary aldosteronism and healthy subjects) and platelet counts (p < 0.001 vs. primary aldosteronism; p = 0.01 vs. essential hypertension) compared to the other groups of subjects. Similar results were obtained for positive proteins of acute-phase response in subjects with pheochromocytoma [C-reactive protein: 0.62 ± 0.52 mg/dl, p < 0.001 vs. healthy subjects (0.08 ± 0.08 mg/dl), p = 0.001 vs. primary aldosteronism (0.17 ± 0.19 mg/dl), p = 0.04 vs. essential hypertension (0.31 ± 0.26 mg/dl); fibrinogen: p = 0.02 vs. primary aldosteronism; orosomucoid: p = 0.005 vs. primary aldosteronism; α2-macroglobulin: p = 0.009 vs. primary aldosteronism]. No significant differences were found in plasma levels of α1-antitrypsin, transferrin and prealbumin. Tumor removal led to a significant decrease in leukocyte (p = 0.004), neutrophil (p = 0.007) and platelet count (p = 0.003) and also to a significant decrease in acute-phase proteins (C-reactive protein: p = 0.03, fibrinogen: p = 0.008, α1-antitrypsin: p = 0.003, orosomucoid: p = 0.04). Conclusions: Chronic catecholamine excess in pheochromocytoma is accompanied by an increase in inflammation markers which was reversed by the tumor removal.

1 September 2001 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
JŠJan Škrha
Jan Škrha
MPMartin Prázný
Martin Prázný
THTomáš Haas
Tomáš Haas
JKJan Kvasnička
Jan Kvasnička
BKBohdana Kalvodová
Bohdana Kalvodová